Accenture and Organon Team Up to Drive Digital Transformation for Better Patient and Employee Experiences
Accenture (NYSE: ACN) has partnered with Organon (NYSE: OGN) to transform the company’s enterprise resource planning (ERP) technology using SAP S4/HANA® on AWS. This collaboration aims to enhance the digital core of Organon, improving patient and employee experiences through real-time analytics and streamlined operations. The transition to a cloud-based platform is expected to minimize disruptions and support growth through efficient data management. Accenture’s expertise will help Organon navigate this modernization process effectively.
- Accenture's partnership with Organon focuses on modernizing ERP technology for improved operational efficiency.
- The move to SAP S4/HANA® on AWS will enhance real-time analytics capabilities for better decision-making.
- Accenture's approach aims to simplify processes while minimizing disruptions during the implementation.
- The substantial investment in new technology may increase short-term operational costs for Organon.
- Dependence on cloud solutions raises concerns about data security and system reliability.
Accenture to help build Organon’s next generation enterprise capabilities with SAP S4/HANA® on AWS
Making Organon’s operating model fit for the future (Photo: Business Wire)
With a standardized technology platform that integrates business processes and people, Organon will have real-time analytics at its fingertips, allowing it to respond more rapidly to the needs of its patients, customers, and employees.
Organon will use SAP S/4HANA® to help simplify systems and processes while minimizing disruption. Accenture will deploy the solution using AWS cloud hosting for scalability and a faster implementation time, leveraging the jointly developed accelerators with AWS via the
“We are excited to be modernizing technology, simplifying processes and supporting the flexible adoption of partners, and providing connected real-time data,” said
“Organon is establishing a foundation that will be essential to its ability to continue to grow as a company and fulfill its promise to the various communities it serves, including patients and its employees,” said
Accenture’s Life Sciences industry group helps pharmaceutical, biotech, medical technology, distributor and consumer health companies combine the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world. To learn more, visit https://www.accenture.com/us-en/industries/life-sciences-index.
For more information, visit http://www.organon.com and connect on LinkedIn and Instagram.
About Accenture
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 624,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.
Any statements in this release that are not historical facts are forward-looking statements as defined in the
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in
Copyright ©2021 Accenture. All rights reserved. Accenture and its logo are registered trademarks of Accenture.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211117006234/en/
Accenture
+1 678 657 7515 (office)
+1 404 409 9430 (mobile)
marchell.gillis@accenture.com
Source: Accenture
FAQ
What is Accenture's role in Organon's ERP transformation?
How will the partnership between Accenture and Organon benefit patients?
What technology is being used in Organon's ERP project?